INTRODUCTION
Foeniculum vulgare Miller, (family Umbelliferae) is an annual, biennial or perennial aromatic herb, depending on the variety, which has been known since antiquity in Europe and Asia Minor. The leaves, stalks and seeds (fruits) of the plant are edible 1 . Extracts of Foeniculum vulgare Miller (fennel) seeds are used as an anti-inflammatory agent in Turkish traditional medicine 2 . The antiinflammatory, hypoglycemic and hepatoprotective effects of fennel were dem-onstrated in previous studies [3] [4] [5] [6] [7] . The volatile components of fennel seed extracts are trans-anethole, fenchone, methylchavicol, limonene, alpha-pinene, camphene, β-pinene, β-myrcene, α-phellandrene, 3-carene, camphor, and cisanethole 8 . The major components of the fennel seed essential oil are alpha-pinene, limonene, fenchone, methychavicol and trans-anethole 6 .
In our previous work, we demonstrated the anti-inflammatory and hypoglycemic activities of volatile oil extract of fennel [3] [4] [5] [6] [7] . In order to determine the fennel component(s) responsible for these activities and to determine its lethal dose levels, this study investigates alpha-pinene, a major component of volatile oil extract of fennel.
METHODOLOGY Animals
Sprague-Dawley rats and Mus musculus Swiss albino mice were maintained in the animal house. The animals were housed in standard cages with pelleted food and water ad libitum, at room temperature (22±2 0 C) with a 12h light-dark cycle. Ethical approval was obtained from the Animal Ethics Committee.
Chemicals
(1R)-(+)-α-pinene (C 10 H 16 ), lambda-carrageenan Type IV, indomethacin and alloxan were obtained from Sigma (Steinheim, Germany), and glibenclamide was obtained from Nobel (Istanbul, Turkey).
Acute toxicity
Swiss albino mice were randomly assigned to nine groups with six animals in each group. The control group was treated with isotonic saline solution (ISS) (0.9% NaCl), and the other eight groups were treated with alpha-pinene given intraperitoneally (ip) by Hamilton and insulin injectors in increasing dosages of 0.05, 0.10, 0.20, 0.40, 0.80, 1.60, 2.40 and 3.20 mL/kg body weight. The mortality in each cage was assessed 72 h after administration of alpha-pinene. The percentage mortalities were converted to probits. Regression lines were fitted by the method of least squares and confidence limits for the LD 1 , LD 10 .
Anti-inflammatory activity
The method of Winter et al was used with slight modification 11 . Forty-two rats were divided into seven groups of six animals each. The rats were starved for 12 h and deprived of water only during the experiment. Water deprivation was em-ployed to ensure uniform hydration and to minimize variability in edematous response. Inflammation of the hind paw was induced by injecting 0.05 mL of fresh lambda carrageenan (phlogistic agent) into the subplantar surface of the right hind paw. The control group-I was given ISS (0.1 mL) and the control group-II was given ethyl alcohol (0.1 mL). The third group (reference group) received the anti-inflammatory agent indomethacin (3 mg/kg, ip), while the remaining four groups received alpha-pinene at doses of 0.05, 0.10, 0.25 and 0.50 mL/kg, i.p by Hamilton injector 12 . The doses utilized in the current study were chosen according to LD 1 value (LD 1 = 0.744 mL/kg).
Foot volume was measured by a displacement technique using a plethysmometer (Ugo Basile 7140 plethysmometer, Italy), immediately before and three hours after the 0.05 mL of fresh lambda carrageenan injection. The percentage inhibition of the inflammatory reaction was determined for each animal by comparison with controls and calculated by the formula 10 :
where dt is the difference in paw volume in the drug-treated group and dc the difference in paw volume in the control group.
Preparation of alloxan diabetic mice
Diabetes was induced by i.p. injections of 150 mg/kg alloxan monohydrate prepared in ISS three times with 48 h intervals. Before injections were given mice were starved for 18 h 13 . Seven days after the last injection, fasting blood glucose levels were measured and mice with fasting blood glucose levels of 200 mg/dL and over were taken into the study 14 .
Hypoglycemic activity in normal and diabetic mice
Diabetic animals were randomly divided into three groups of six animals each. Group I mice received 0.1 mL ISS i.p. The animals in group II were treated orally with 3.0 mg/kg glibenclamide, a hypoglycemic agent, used as reference. Group III received i.p. injection of 0.25 mL/kg alpha-pinene by Hamilton injector. The same protocol described above was applied in three groups of normal mice. Fasting blood glucose levels were measured after 18 h of fasting just before the treatment and 1, 2, 4 and 24 h after the treatment using the glucose oxidase peroxidase method (Abbott, United Kingdom).
Statistical analysis
Results were reported as mean ± standard error of mean (SEM). The total variation was analyzed by performing a one-way analysis of variance (ANOVA). Least Significant Difference (LSD) test, Dunnet test and Tukey's HSD (Honestly Significant Difference) test were used for determining significance. Probability levels of less than 0.05 were considered significant. The medium effective dose (ED 50 ) value was calculated by non-linear regression analysis (SigmaPlot 2004 for Windows Version 9.01).
RESULTS AND DISCUSSION

Acute toxicity
The lethal doses of alpha-pinene are presented in Table 1 . The intraperitoneal medium lethal dose (LD 50 ) value for the total number of animals was found to be 2.076 mL/kg. Table 2 shows the anti-inflammatory effects of intraperitoneally administered alpha-pinene on carrageenan induced paw edema in rats. Alpha-pinene showed significant anti-inflammatory effect in two doses studied (0.025 mL/kg and 0.50 mL/kg); peak response was obtained with 0.50 mL/kg alpha-pinene (60.33% decrease in inflammation) and 0.05 mL/kg alpha-pinene caused a lesser degree of inhibition of the inflammation (18.97%). Compared to the controls, the greatest anti-inflammatory activity was observed in the indomethacin group, with a 87.44% regression of the inflammation. Compared to indomethacin group, alpha-pinene group had significantly lower anti-inflammatory effects at all doses. At 0.05 mL/kg dose the alpha-pinene group showed significantly lower antiinflammatory activity compared to the 0.50 mL/kg dose. The medium effective dose (ED 50 ) value of alpha-pinene was found to be 0.039 mL/kg. 
Anti-inflammatory activity
Hypoglycemic activity
The fasting blood glucose levels of the alloxan diabetic mice are presented in Table 3 . Table 4 demonstrate the levels of fasting blood glucose in normal mice. It was determined that alpha-pinene significantly decreased fasting blood glucose levels at the 2 nd and 24 th hours. It was observed that alpha-pinene significantly increased fasting blood glucose levels in healthy mice at the 1 st and 2 nd hours. In this work, the LD 50 dose of alpha-pinene, a major component of the essential oil of Foeniculum vulgare Mill. was determined to be 2.076 mL/kg.
The current study clearly demonstrated the in vivo anti-inflammatory effect of alpha-pinene at doses of 0.25 mL/kg and 0.50 mL/kg. The ED 50 dose of alphapinene related to its anti-inflammatory activity was found to be 0.039 mL/kg for its.
It has been reported that Bupleurum fruticescens, Salvia species and Helichyrisum species essential oils had anti-inflammtory effects. The anti-inflammatory activity shown by the essential oil can be attributed to the two major components-alpha-pinene and beta-caryophyllene [15] [16] [17] . The results of these studies are consistent with those of the current study. Zhou et al. reported that alpha-pinene inhibits the nuclear translocation of NF-kappa B induced by lipopolysaccharide (LPS) in THP-1 cells 18 . The transcription factor NF-kappa B plays a pivotal role in the activation of multiple inflammatory molecules 19 . Kim et al claimed that alpha-pinene exhibits anti-inflammatory activity through the suppression of mitogen-activated protein kinases (MAPKs) and the nuclear factor-kappa B (NF-κB) pathway in mouse peritoneal macrophages 20 . It can be suggested that alpha-pinene shows its anti-inflammatory effect through the NF-kappa B. Rufino et al. reported that at noncytotoxic concentrations, (+)-α-pinene elicited the most potent inhibition of the IL-1β-induced inflammatory and catabolic pathways, namely, NF-κB and JNK activation and the expression of the inflammatory (iNOS) and catabolic (MMP-1 and -13) genes in human chondrocytes 21 .
